GlassScriptPhysician profile
Olga Fingerman
NPI 1659589992
$730.96
in general payments reported to CMS, 2019-2025
9 companies · $19.22 in 2025
The $19.22 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $426 · 2022: $270 · 2024: $16.25 · 2025: $19.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $35.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $35.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $184.51 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.27 | 2021-2022 | |
| Boston Scientific Corporation | $160.56 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $125.95 | 2021 | |
| Electronic Waveform Lab, INC. | $19.22 | 2025 | |
| Collegium Pharmaceutical, INC. | $15.96 | 2022 | |
| Redhill Biopharma INC. | $15.47 | 2022 | |
| Virtus Pharmaceuticals LLC | $13.23 | 2021 | |
| Baudax Bio INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olga Fingerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.